Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Change in Acquisitions & Divestments: 2018-2024

Historic Change in Acquisitions & Divestments for Abeona Therapeutics (ABEO) over the last 7 years, with Dec 2024 value amounting to $120.2 million.

  • Abeona Therapeutics' Change in Acquisitions & Divestments rose 473.46% to $98.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $233.2 million, marking a year-over-year increase of 234.68%. This contributed to the annual value of $120.2 million for FY2024, which is 131.28% up from last year.
  • Per Abeona Therapeutics' latest filing, its Change in Acquisitions & Divestments stood at $120.2 million for FY2024, which was up 131.28% from $52.0 million recorded in FY2023.
  • Abeona Therapeutics' 5-year Change in Acquisitions & Divestments high stood at $120.2 million for FY2024, and its period low was $52.0 million during FY2023.
  • In the last 3 years, Abeona Therapeutics' Change in Acquisitions & Divestments had a median value of $52.6 million in 2022 and averaged $74.9 million.
  • Per our database at Business Quant, Abeona Therapeutics' Change in Acquisitions & Divestments crashed by 41.75% in 2022 and then soared by 131.28% in 2024.
  • Yearly analysis of 5 years shows Abeona Therapeutics' Change in Acquisitions & Divestments stood at $88.1 million in 2020, then climbed by 2.59% to $90.4 million in 2021, then crashed by 41.75% to $52.6 million in 2022, then dropped by 1.28% to $52.0 million in 2023, then soared by 131.28% to $120.2 million in 2024.